Publications

I. Remera Publications (2008-2021)
  1. Gnansia E, Michon L, Amar E, Estève J. Evidence for a cluster of rare birth defects in the Ain department (France). Birth Defects Res. 2021 Feb 9. doi: 10.1002/bdr2.1876. Epub ahead of print. PMID: 33565281 [lire l’article ou l’extrait]
  2. Yu X, Nassar N, Mastroiacovo P, Canfield M, Groisman B, Bermejo-Sánchez E, Ritvanen A, Kiuru-Kuhlefelt S, Benavides A, Sipek A, Pierini A, Bianchi F, Källén K, Gatt M, Morgan M, Tucker D, Canessa MA, Gajardo R, Mutchinick OM, Szabova E, Csáky-Szunyogh M, Tagliabue G, Cragan JD, Nembhard WN, Rissmann A, Goetz D, Bower C, Baynam G, Lowry RB, Leon JA, Luo W, Rouleau J, Zarante I, Fernandez N, Amar E, et al. Hypospadias prevalence and trends in International Birth Defect Surveillance Systems, 1980-2010. Eur Urol, 2019 ;76 :482-490. [lire l’article ou l’extrait]
  3. Guinamard I, Colin S, Amar E, Addad S, Shayikova A, & Poizat D. (2019). Espérance de Vie Scolaire et Handicap, premiers résultats de l’enquête EVS-H menée auprès d’enfants nés vivants porteurs de malformations congénitales. Les Sciences de l’éducation – Pour l’Ère nouvelle, vol. 52(3), 95-120. [lire l’article ou l’extrait]
  4. Gaillot-Durand L, Brioude F, Beneteau C, Le Breton F, Massardier J, Michon L, Devouassoux-Shisheboran M, Allias F. Placental Pathology in Beckwith-Wiedemann Syndrome According to Genotype/Epigenotype Subgroups. Fetal Pediatr Pathol. 2019 Jan 11:1-13. [lire l’article ou l’extrait]
  5.  Amar E, Michon L, Gnansia E. Hypospadias and environment: A registry-based case-control study, Revue d’Épidémiologie et de Santé Publique, Volume 66, Supplement 5, 2018, Pages S333-S334 [lire l’article ou l’extrait]
  6. Bakker MK, Bergman JEH, Krikov S, Amar E et al.  Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study. BMJ Open. 2019;9(7): e028139. Published 2019 Jul 2. doi:10.1136/bmjopen-2018-028139
    [lire l’article ou l’extrait]
  7. Uk A, Collardeau-Frachon S, Scanvion Q, Michon L, Amar E Assisted reproductive technologies and imprinting disorders: results of a study from a French congenital malformations registry. Eur J Med Genet. 2018 pii: S1769-7212:30165-4. [lire l’article ou l’extrait]
  8. Panchaud A, Rousson V, Vial T, Bernard N, Baud D, Amar E et al. Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services. Br J Clin Pharmacol. 2018, 84: 568-578.
  9. Amar E. Malformations et facteurs environnementaux. Méd. Périnat. (2017) 9:73-80
    [lire l’article ou l’extrait]
  10. Amar E. Quand un agrégat de malformations rencontre une agence de santé publique : une impression de déjà-vu ? Environnement, Risques & Santé, 2016, 15 : 465-8. [lire l’article ou l’extrait]
  11. Panchaud A, Baud D, Vial T, Bernard N, Amar E et al. Pregnancy outcome following maternal exposure to metformin: preliminary results of a collaborative ENTIS and Motherisk study. Conference : ENTIS OTIS meeting, At Toronto, Volume: Birth Defects Research Part A: Clinical and Molecular Teratology 2014; 100(7):521.
    [Lire l’article ou l’extrait]
  12. Ottomani H. Gouraud A., P. Jonville-Bera, A. Dautriche, P. Carlier, Amar E, T. Vial
    First-trimester exposure to valproic acid treatment in bipolar disorders: a prospective comparative study using the Terappel database. Fundamental and Clinical Pharmacology May 2014.
  13. Ottomani H, Gouraud A, Jonville-Bera AP, Dautriche A, Carlier P, Amar E, Vial T. Pregnancy outcome after first trimester exposure to valproic acid used in bipolar disorders. Birth Defect Research Part A 2014; 100:519-559.
  14. Les malformations congénitales en Rhône Alpes. Dossiers santé environnement de l’ORS, 2012.
    [Lire l’article ou l’extrait]
  15. Feldkamp ML, Botto LD, Amar Eet al.Cloacal exstrophy: An epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet, 2011, Part C: Seminars in Medical Genetics Special Issue: Very Rare Defects: What Can We Learn? 157: 333-343.
    [lire l’article ou l’extrait]
  16. Siffel C, Correa A, Amar E, et al.Bladder exstrophy: an epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research, and an overview of the literature. Am J Med Genet, 2011, Part C: Seminars in Medical Genetics Special Issue: Very Rare Defects: What Can We Learn? 157: 321-332
  17. Mutchinick OM, Luna-Munoz L, Amar E, et al. Conjoined twins: A worldwide collaborative epidemiological study of the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet Part C: Seminars in Medical Genetics, 2011, Special Issue: Very Rare Defects: What Can We Learn? 274-287.
    [lire l’article ou l’extrait]
  18. Orioli IM, Amar E, Bakker MK, et al. Sirenomelia: an epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research, and literature review. Am J Med Genet 2011, Part C, Seminars in Medical Genetics: 157:358-373.
    [lire l’article ou l’extrait]
  19. Cordier S, Lehébel A, Amar E, Anzivino-Viricel L, Hours M, Monfort C, Chevrier C, Chiron M, Robert-Gnansia E. Maternal residence near municipal waste incinerators and the risk of urinary tract birth defects. Occup Environ Med. 2010; 67:493-9.
    [lire l’article ou l’extrait]
  20. Leoncini E, Botto LD, Cocchi G, Annerén G, Bower C, Halliday J, Amar E, et al. How valid are the rates of Down syndrome internationally? Findings from the international Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet A. 2010; 152A:1670-80.
    [lire l’article ou l’extrait]
  21. Cocchi G, Gualdi S, Bower C, Halliday J, Jonsson B, Myrelid A, Mastroiacovo P, Amar E et al. International trends of Down Syndrome 1993/2004: Births in relation to maternal age and terminations of pregnancies. Birth Defects Res A Clin Mol Teratol. 2010;88: 474-9.
    [lire l’article ou l’extrait]
  22. Rousseau T, Amar E, Ferdynus C, et al. J Gynecol Obstet Biol Reprod (Paris). 2010; 39: 290-6. Variations in the prevalence of Down’s syndrome in the French population between 1978 and 2005.
    [lire l’article ou l’extrait]
  23. Rankin J, Cans C, Garne E, Colver A, Dolk H, Amar E, et al. Congenital anomalies in children with cerebral palsy: a population-based record linkage study. Dev Med Child Neurol. 2010, 52, 345-51
    [lire l’article ou l’extrait]
  24. Congenital anomalies in children with cerabral palsy: a population-based record linkage study. Rankin J, Cans C, Garne E, Colver A, Dolk H, Amar E, et al. Dev Med Child Neurol. 2009 Sep 8. 
  25. Frequency of holoprosencephaly in the International Clearinghouse Birth Defects Surveillance Systems : Searching for population variations Birth Defects Research Part A : Clinical and Molecular teratology. 2009. Volume 82 Issue 8, Pages 585-591. 
  26. Création d’un registre : exemple du Registre des malformations en Rhône-Alpes (Remera); Creation of a registry: the case of the Rhône-Alpes registry of congenital malformations (Remera)  Emmanuelle Amar Registre des malformations en Rhône-Alpes, Faculté de médecine Laennec, Lyon, France [lire l’article ou l’extrait]
  27. État des lieux des registres de malformations congénitales en France en 2008.  Perthus I, Amar E, De Vigan C, Doray B, Francannet C.  BEH 2008 jul; 28-29:246-8
II. Étude multicentrique exploitant les données de Remera
  1. Goldsmith S, Mcintyre S, Andersen GL, Gibson C, Himmelmann K, Blair E, Badawi N, Smithers-Sheedy H, Garne E; Comprehensive CA-CP Study Group. Congenital anomalies in children with pre- or perinatally acquired cerebral palsy: an international data linkage study. Dev Med Child Neurol. 2020 Jun 24. [lire l’article ou l’extrait]
III. International journals with editorial committee (1981-2010)
  1. Robert JM, Guibaud P, Robert E. A local outbreak of femoral hypoplasia or aplasia and Femoral Fibula Ulnar Complex. J Genet Hum, 1981, 29, 379-394.
    [lire l’article ou l’extrait]
  2. Robert E, Roch-Suzuki R, Boggio D, Haag P. Incidence des malformations des voies excrétrices urinaires (VEU) dans la région Rhône-Alpes. A propos de 1357 cas d’enfants atteints identifiés pendant une période de 7 ans (1976-1982) – J Génét Hum, 1984, 32, 2, 107-111.
  3. Robert E, Löfkvist E, Mauguière F, Robert JM. Evaluation of drug therapy and teratogenic risk in a Rhône-Alpes district population of pregnant epileptic women. Eur Neurol, 1986, 25: 436-443.
  4. Bertollini R, Källén B, Mastroiacovo P, Robert E. Anticonvulsant drugs in monotherapy. Effects on the fetus. Eur J Epidemiol, 1987, 3, 164-171.
    [lire l’article ou l’extrait]
  5. A communication from the International Clearinghouse for Birth Defects Monitoring Systems: The epidemiology of bladder exstrophy and epispadias. Teratology, 1987, 36: 221-227.
    [lire l’article ou l’extrait]
  6. Robert E. Valproic acid as a human teratogen. Cong Anom, 1988, 28 (Suppl): S71-S80.
  7. Källén B, Robert E, Mastroiacovo P, Martinez-Frias ML, Castilla EE, Cocchi G. Anticonvulsant drugs and malformations. Is there a drug specificity? Eur J Epidemiol, 1989, 5, 31-36 .[lire l’article ou l’extrait]
  8.  International Clearinghouse for Birth Defects Monitoring Systems. Conjoined twins – An epidemiological study based on 312 cases. Acta Genet Med Gemellol, 1991,40: 325-335.
  9. Pradat E, Robert E, Laumon B. Ovulation induction and neural tube defects: a registry study. Reprod Toxicol, 1991, 5 : 83-84.
  10. Källén B, Castilla EE, Kringelbach M, Lancaster PAL, Martinez-Frias ML, Mastroiacovo P, Mutchinick O, Robert E. Parental subfertility, and infant hypospadias: an international case-control study. Teratology, 1991, 44: 629-634.
  11. Källén B, Mastroiacovo P, Lancaster PAL, Mutchinick O, Kringelbach M, Martinez-Frias ML, Robert E, Castilla EE. Oral contraceptives in the etiology of isolated hypospadias. Contraception, 1991, 44 : 173-182.
  12. Robert E, Martínez-Frías ML. What does it mean to be a member of the Clearinghouse ? Int J Risk Saf Med. 1991;2(5):249-54.
    [lire l’article ou l’extrait]
  13. Robert E. Handling surveillance types of data on birth defects and exposures during pregnancy. Reprod Toxicol, 1992, 6: 205-209.
  14. Källén B, Martinez-Frias ML, Castilla EE, Robert E, Lancaster PAL, Kringelbach M, Mutchinick O, Mastroiacovo P. Hormone therapy during pregnancy and isolated hypospadias: an international case-control study. Int J of Risk & Safety in Medicine, 1992,3: 183-198.
  15. Källén B, Castilla EE, Robert E, Lancaster PAL, Kringelbach M, Mutchinick O, Martinez-Frias ML, Mastroiacovo P. An international case-control study on hypospadias. The problem of variability and the beauty of diversity. Eur J Epidemiol, 1992, 8: 256-263.
  16. Vial T, Robert E, Carlier P, Bertolotti E, Brun A. First trimester exposure to anorectics: a French collaborative study with special reference to dexfenfluramine. Int J Risk and Safety in Medicine, 1992,3: 207-214.
  17. Mastroiacovo P, Källén B, Knudsen LB, Lancaster PAL, Castilla EE, Mutchinick O, Robert E. Absence of limbs and gross body wall defects. An epidemiological study of related rare malformation conditions. Teratology, 1992, 46 :447-464.
    [lire l’article ou l’extrait]
  18. Källén B, Castilla EE, Lancaster PAL, Mutchinick O, Knudsen LB, Martinez-Frias ML, Mastroiacovo P, Robert E. The cyclops and the mermaid: an epidemiological study of two types of rare malformation. J Med Genet, 1992, 29 : 30-35.
    [lire l’article ou l’extrait]
  19. Källén B, Knudsen LB, Mastroiacovo P, Lancaster PAL, Castilla EE, Mutchinick O, Robert E. Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformation registries. An international feasibility study. Int J Epidemiol, 1993, 22 :107-115.
  20. Robert E. Birth defects and high voltage powerlines: an exploratory study based on registry data. Reprod Toxicol, 1993, 7 : 283-286.
  21. Robert E, Mutchinick O, Mastroiacovo P, Knudsen LB, Dalveit AK, Castilla EE, Lancaster PAL, Källén B, Cocchi G. An international collaborative study of the epidemiology of esophageal atresia or stenosis. Reprod Toxicol, 1993, 7 : 405-421.
    [lire l’article ou l’extrait]
  22. Robert E, Källén K. In utero exposure to carbamazepine. Effects on the fetus. Issues and Reviews in Teratology, 1994, vol 7, 37-55.
  23. Robert E, Vollset SE, Botto L, Lancaster PAL, Merlob P, Mastroiacovo P, Cocchi G, Ashisawa M, Sakamoto S, Orioli I. Malformation surveillance and maternal drug exposure: the MADRE project. Int J Risk Safety in Medicine, 1994, 6 : 75-118.
    [lire l’article ou l’extrait]
  24. Källén B, Castilla EE, Cocchi G, Dalveit AK, Mastroiacovo P, Robert E, An international collaborative study of sex ratio and twinning of neural tube defects. Teratology, 1994, 50 :322-331.
  25. Robert E, Francannet C, Shaw G. Neural tube defects and maternal weight reduction in early pregnancy. Reprod Toxicol, 1995, 9 : 57-59
    [lire l’article ou l’extrait]
  26. Harris J, Källén B, Robert E. Descriptive epidemiology of alimentary tract atresias. Teratology, 1995, 52: 15-29.
    [lire l’article ou l’extrait]
  27. Robert E. Un exemple de détection d’un effet tératogène dans le cadre d’un registre de malformations : Depakine et Spina Bifida. Rev Epidemiol Santé Publ, 1996, S78-S81.
  28. Robert E, Harris JA, Robert O, Selvin S. Case-control study on maternal residential proximity to high voltage power lines and congenital malformations in France. Paediatric and Perinatal Epidemiology, 1996, 10 :32-38.
    [lire l’article ou l’extrait]
  29. Laumon B, Martin JL, Collet P, Bertucat I, Verney MP, Robert E. Exposure to organic solvents during pregnancy and oral clefts: a case-control study. Reprod Toxicol, 1996, 10 :15-19.
  30. Källén B, Robert E, and Harris JA. The descriptive epidemiology of anophthalmia and microphthalmia. Int J Epidemiol, 1996, 25 :1009-1016.
    [lire l’article ou l’extrait]
  31. Robert E, Källén B, and Harris JA. The epidemiology of orofacial clefts. Some general epidemiological characteristics. J Craniofac Genet Dev Biol, 1996, 16 :234-241
    [lire l’article ou l’extrait]
  32. Källén B, Harris JA, and Robert E. The epidemiology of orofacial clefts. Associated malformations. J Craniofac Genet Dev Biol, 1996, 16 :242-248.
    [lire l’article ou l’extrait]
  33. Harris JA, Källén B, and Robert E. The epidemiology of anotia and microtia. J Med Genet, 1996, 33 :809-813.
    [lire l’article ou l’extrait]
  34. Källén B, Mastroiacovo P, Robert E. Major congenital malformations associated with Down syndrome. Am J Med Genet, 1996; 65:160-166. [lire l’article ou l’extrait]
  35. Harris JA, Robert E and Källén B. The epidemiology of choanal atresia with special reference to the CHARGE association. Pediatrics, 1997, 99:363-367.
    [lire l’article ou l’extrait]
  36. Robert E, Harris JA, and Källén B. The epidemiology of diaphragmatic hernia. Eur J Epidemiol, 1997, 13: 665-673.
    [lire l’article ou l’extrait]
  37. Robert E, Harris JA, and Källén B. The epidemiology of preaxial limb malformations. Toxicol., 1997, 11 : 653-662.
    [lire l’article ou l’extrait]
  38. Dolk H, Vrijheid M, Armstrong B, Abramsky L, Bianchi F, Garne E, Nelen V, Robert E, Scott JES, Stone D, Tenconi R. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Lancet, 1998, 352 :423-427.
  39. Källén B, Robert E, Harris JA. Associated malformations in infants and fetuses with upper or lower neural tube defects. Teratology, 1998, 57 :56-63.
    [lire l’article ou l’extrait]
  40. Källén KBM, Castilla EE, Dutra MG, Mastroiacovo P, Robert E, Källén B. A modified method for the epidemiological analysis of registry data on infants with multiple malformations. Int J Epidemiol, 1999, 28: 701-710.
    [lire l’article ou l’extrait]
  41. Mastroiacovo P, Mazzone T, Addis A, Eléfant E, Carlier P, Vial T, Garbis H, Robert E, Bonati M, Ornoy A, Finardi A, Schaefer C, Caramelli L, Rodriguez-Pinilla E, Clementi M. High vitamin A intake in early pregnancy and major malformations : a multicenter prospective controlled study. Teratology, 1999, 59 :7-11.
  42. Robert E. Intra-uterine effects of electromagnetic fields-(low frequency, mid frequency RF, and microwave) : review of epidemiologic studies. Teratology, 1999, 59 :292-298.
  43. Rosano A, Smithells RW, Cacciani L, Botting B, Castilla E, Cornel M, Erickson D, Goujard J, Irgens L, Merlob P, Robert E, Siffel C, Stoll C, Sumiyoshi Y. Time trends in neural tube defects prevalence in relation to preventive strategies : an international study. J Epidemiol Comm Health, 1999, 53 : 630-635.
  44. Klein, SK, Cans C, Robert E, and Jouk PS. Efficacy of routine fetal ultrasound screening for congenital heart disease in Isere county, France. Prenat Diagn 1999, 19 : 318-322.
    [lire l’article ou l’extrait]
  45. Källén K, Robert E, Mastroiacovo P, Castilla EE, Källén B. Charge Association in newborns: a registry-based study. Teratology, 1999, 60 : 334-343.
    [lire l’article ou l’extrait]
  46. Källén K, Castilla EE, Robert E, Mastroiacovo P, Källén B. OEIS Complex: a population study. Am J Med Genet, 2000, 92: 62-68.
    [Lire l’article ou l’extrait]
  47. Källén BAJ, Robert E. Drinking water chlorination and delivery outcome – a registry-based study in Sweden. Reprod Toxicol, 2000, 14 : 303-309.
  48. Arpino C, Brescianini S, Robert E, Castilla E, Cocchi G, Cornel MC, de Vigan C, Lancaster PAL, Merlob P, Sumiyoshi Y, Zampino G, Renzi C, Rosano A, Mastroiacovo P. Teratogenic effects of antiepileptic drugs : use of an international database on malformations and drug exposure (MADRE). Epilepsia, 2000, 41 :1436-1443.
    [Lire l’article ou l’extrait]
  49. Robert E. Risk factors for limb reduction defects. Congenital Anomalies, 2000, 40 : S20-S24.
  50. Harris J, Robert E, Kallén B. Epidemiologic characteristics of kidney malformations. Eur J Epidemiol 2000; 16:985-92
    [Lire l’article ou l’extrait]
  51. Källén K, Mastroiacovo P, Castilla EE, Robert E, Källén B. VATER non-random association of congenital malformations: study based on data from four malformation registers. Am J Med Genet. 2001, 101:26-32.
    [Lire l’article ou l’extrait]
  52. Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J, Clementi M. Adverse effects of prenatal methimazole exposure. 2001 ;64 :262-266.
  53. Bonnot O, Vollset SE, Godet PF, D’Amato T, Robert E. Maternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformations. J Clin Psychopharmacol. 2001 ;21:456-8.
    [Lire l’article ou l’extrait]
  54. Vrijheid M, Dolk H, Armstrong B, Abramsky L, Bianchi F, Fazarinc I, Garne E, Ide E, Nelen V, Robert E, Scott JES, Stone D, Tenconi R. Chromosomal congenital anomalies, and residence near hazardous waste landfill sites. Lancet, 2002, 359 : 320-22
    [lire l’article ou l’extrait]
  55. Vrijheid M, Dolk H, Armstrong B, Boschi G, Busby A, Jorgensen T, Pointer P, and the EUROHAZCON collaborative group. Hazard potential ranking of hazardous waste landfill sites and risk of congenital anomalies. Occup Environ Med, 2002 ;59 : 768-776.
  56. Robert-Gnansia E, Saillenfait AM. Physical and Chemical Factors in the Home and Workplace before and during Pregnancy. Community Genet. 2002;5(1):78-85.
    [lire l’article ou l’extrait]
  57. Pradat P, Francannet C, Harris JA, Robert E. The Epidemiology of Cardiovascular Defects, Part I: A Study Based on Data from Three Large Registries of Congenital Malformations. Pediatr Cardiol 2003, 24: 195-221.
    [Lire l’article ou l’extrait]
  58. Harris JA, Francannet C, Pradat P, Robert E. The Epidemiology of Cardiovascular Defects, Part 2: A Study Based on Data from Three Large Registries of Congenital Malformations. Pediatr Cardiol 2003 24 : 222-235.
    [lire l’article ou l’extrait]
  59. Guillem P, Fabre B, Cans C, Robert-Gnansia E, Jouk PS. Trends in elective terminations of pregnancy between 1989 and 2000 in a French county (the Isère). Prenat Diagn, 2003, 23 : 877-883.
    [lire l’article ou l’extrait]
  60. Pradat P, Robert-Gnansia E, Di Tanna GL, Rosano A, Lisi A, Mastroiacovo P First trimester exposure to corticosteroids and oral clefts. Birth Defects Research A, 2003; 67: 968-970
    [lire l’article ou l’extrait]
  61. Lazjuk G, Verger P, Gagnière B, Kravchuk Zh, Zatsepin I, Robert-Gnansia E. The congenital anomalies registry in Belarus: a tool for assessing the public health impact of the Chernobyl accident. Reprod Toxicol. 2003 Nov-Dec;17(6):659-66.
    [lire l’article ou l’extrait]
  62. Cordier S, Chevrier C, Robert-Gnansia E, Lorente C, Brula P, Hours M. Risk of congenital anomalies in the vicinity of solid waste incinerators. Occup Environ Med, 2004, 61 : 8-15.
    [lire l’article ou l’extrait]
  63. Källén K, Robert E, Castilla EE, Mastroiacovo P, Källén B. Relation between oculo-auriculo-vertebral (OAV) dysplasie and three other non-random associations of malformations (VATER, CHARGE and OEIS). Am J Med Genet, 2004 127A: 26-34.
    [lire l’article ou l’extrait]
  64. Chevrier C, Perret C, Bahuau M, Nelva A, Herman C, Francannet C, Robert-Gnansia E, Cordier S. Interaction between the ADH1C polymorphism and maternal alcohol intake in the risk of nonsyndromic oral clefts: An evaluation of the contribution of child and maternal genotypes. Birth Defects Res A Clin Mol Teratol, 2004, 73: 114-122.
    [lire l’article ou l’extrait]
  65. Robert-Gnansia E. Risk for children exposed prenatally to valproic acid. Reprod Toxcol, 2004, 19: 246-7. NATO Advanced Research Workshop on “Drugs in Pregnancy: Consensus Conference on Teratogen Information Services”, Prague, 16–18 April 2004
  66. Cochat P, Decramer S, Robert-Gnansia E, Dubourg L, Audra P. Renal outcome of children exposed to cyclosporine in utero. Transplant Proc. 2004 Mar;36(2 Suppl):208S-210S. Review.
    [lire l’article ou l’extrait]
  67. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, de Vigan C, de Walle H, Feijoo M, Irgens LM, Mc Donnell B, Merlob P, Ritvanen A, Scarano G, Siffel C, Metneki J, Stoll C, Smithells R, Goujard J. International retrospective cohort study of neural tube defects in relation to folic acid recommendations :are the recommendations working ? BMJ, 2005;330:571.
    [lire l’article ou l’extrait]
  68. Kallen B, Robert-Gnansia E. Maternal drug use, fertility problems, and infant craniostenosis. Cleft Palate Craniofac J. 2005; 42:589-93.
    [lire l’article ou l’extrait]
  69. Jaillet J, Robert-Gnansia E, Till M, Vinciguerra C, Edery P. Biliary lithiasis in early pregnancy and abnormal development of facial and distal limb bones (Binder syndrome): a possible role for vitamin K deficiency. Birth Defects Res A Clin Mol Teratol. 2005; 73:188-93.
    [lire l’article ou l’extrait]
  70. Lisi A, Botto LD, Rittler M, Castilla E, Bianchi F, Botting B, De Walle H, Erickson JD, Gatt M, De Vigan C, Irgens L, Johnson W, Lancaster P, Merlob P, Mutchinick OM, Ritvanen A, Robert E, Scarano G, Stoll C, Mastroiacovo P. Sex and congenital malformations: An international perspective. Am J Med Genet A. 2005 ; 134A :49-57.
    [lire l’article ou l’extrait]
  71. Busby A, Abramsky L, Dolk H, Armstrong B, Addor MC, Anneren G, Armstrong N, Baguette A, Barisic I, Berghold A, Bianca S, Braz P, Calzolari E, Christiansen M, Cocchi G, Daltveit AK, De Walle H, Edwards G, Gatt M, Gener B, Gillerot Y, Gjergja R, Goujard J, Haeusler M, Latos-Bielenska A, McDonnell R, Neville A, Olars B, Portillo I, Ritvanen A, Robert-Gnansia E, Rösch C, Scarano G, Steinbicker V. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol. 2005 Sep-Oct;20(3):393-402. Erratum in: Reprod Toxicol. 2006 Jan;21(1):116.
    [lire l’article ou l’extrait]
  72. Gallot D, Marceau G, Coste K, Hadden H, Robert-Gnansia E, Laurichesse H, Déchelotte PJ, Labbé A, Dastugue B, Lémery D, Sapin V. Congenital diaphragmatic hernia: a retinoid-signaling pathway disruption during lung development? Birth Defects Res A Clin Mol Teratol. 2005 Aug;73(8):523-31.
    [lire l’article ou l’extrait]
  73. Garbis H, Elefant E, Diav-Citrin O, Mastroiacovo P, Schaefer C, Vial T, Clementi M, Valti E, McElhatton P, Smorlesi C, Rodriguez EP, Robert-Gnansia E, Merlob P, Peiker G, Pexieder T, Schueler L, Ritvanen A, Mathieu-Nolf M. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services. Reprod Toxicol. 2005 Mar-Apr;19(4):453-8.
    [lire l’article ou l’extrait]
  74. Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, van Tonningen MR, Clementi M, De Santis M, Robert-Gnansia E, Valti E, Malm H, Ornoy A. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther. 2005 Feb 1;21(3):269-75
    [lire l’article ou l’extrait]
  75. Chevrier C, Dananche B, Bahuau M, Nelva A, Herman C, Francannet C, Robert-Gnansia E, Cordier S. Occupational exposure to organic solvent mixtures during pregnancy and the risk of nonsyndromic oral clefts. Occup Environ Med. 2006; 63:617-23.
    [lire l’article ou l’extrait]
  76. Botto LD, Robert-Gnansia E, Siffel C, Harris J, Borman B, Mastroiacovo P. Fostering international collaboration in birth defects research and prevention: a perspective from the International Clearinghouse for Birth Defects Surveillance and Research. Am J Public Health. 2006 ;96:774-80.
    [lire l’article ou l’extrait]
  77. Botto LD, Lisi A, Bower C, Canfield MA, Dattani N, De Vigan C, De Walle H, Erickson DJ, Halliday J, Irgens LM, Lowry RB, McDonnell R, Metneki J, Poetzsch S, Ritvanen A, Robert-Gnansia E, Siffel C, Stoll C, Mastroiacovo P. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol. 2006 Oct;76(10):693-705.
    [lire l’article ou l’extrait]
  78. Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. J Thromb Haemost. 2006 Jun;95(6):949-57.
    [lire l’article ou l’extrait]
  79. Schulte-Hermann R, Wogan GN, Berry C, Brown NA, Czeizel A, Giavini E, Holmes LB, Kroes R, Nau H, Neubert D, Oesch F, Ott T, Pelkonen O, Robert-Gnansia E, Sullivan FM. Analysis of reproductive toxicity and classification of glufosinate-ammonium. Regul Toxicol Pharmacol. 2006 Apr;44(3 Suppl 1):S1-76. Epub 2006 Feb 28.
    [lire l’article ou l’extrait]
  80. Pasquier JC, Morelle M, Bagouet S, Moret S, Luo ZC, Rabilloud M, Gaucherand P, Robert-Gnansia E. Effects of residential distance to hospitals with neonatal surgery care on prenatal management and outcome of pregnancies with severe fetal malformations. Ultrasound Obstet Gynecol. 2007; 29:271-5.
    [lire l’article ou l’extrait]
  81. Mastroiacovo P, Lisi A, Castilla EE, Martinez-Frias ML, Bermejo E, Marengo L, Kucik J, Siffel C, Halliday J, Gatt M, Anneren G, Bianchi F, Canessa MA, Danderfer R, de Walle H, Harris J, Li Z, Lowry RB, McDonell R, Merlob P, Metneki J, Mutchinick O, Robert-Gnansia E, Scarano G, Sipek A, Potzsch S, Szabova E, Yevtushok L. Gastroschisis and associated defects: An international study. Am J Med Genet A. 2007; 143:660-71.
    [lire l’article ou l’extrait]
  82. Chevrier C, Perret C, Bahuau M, Zhu H, Nelva A, Herman C, Francannet C, Robert-Gnansia E, Finnell RH, Cordier S.   Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of non-syndromic oral clefts. Am J Med Genet A. 2007; 143:248-57.
    [lire l’article ou l’extrait]
  83. Gallot D, Boda C, Ughetto S, Perthus I, Robert-Gnansia E, Francannet C, Laurichesse-Delmas H, Jani J, Coste K, Deprest J, Labbe A, Sapin V, Lemery D. Prenatal detection and outcome of congenital diaphragmatic hernia: a French registry-based study. Ultrasound Obstet Gynecol. 2007; 29:276-83.
    [lire l’article ou l’extrait]
  84. Chevrier C, Perret C, Bahuau M, Nelva A, Herman C, Francannet C, Robert-Gnansia E, Cordier S. Fetal and maternal CYP2E1 genotypes and the risk of nonsyndromic oral clefts. Am J Med Genet A. 2007; 143A:1382-5
    [lire l’article ou l’extrait]
  85. Tomson T, Battino D, French J, Harden C, Holmes L, Morrow J, Robert-Gnansia E, Scheuerle A, Vajda F, Wide K, Gordon J. Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav. 2007; 11:277-82.
    [lire l’article ou l’extrait]
  86. Guillem P, Cans C, Robert-Gnansia E, Aymé S, Jouk PS. Rare diseases in disabled children: an epidemiological survey. Arch Dis Child. 2008 Feb; 93:115-8. Epub 2007 Oct 17.
    [lire l’article ou l’extrait]
  87. Zatsepin I, Verger P, Robert-Gnansia E, Gagnière B, Tirmarche M, Khmel R, Babicheva I, Lazjuk G. Down syndrome time-clustering in January 1987 in Belarus: link with the Chernobyl accident? Reprod Toxicol. 2007 Nov-Dec;24(3-4):289-95. Epub 2007 Jun 14.
    [lire l’article ou l’extrait]
  88. Rittler M, López-Camelo JS, Castilla EE, Bermejo E, Cocchi G, Correa A, Csaky-Szunyogh M, Danderfer R, De Vigan C, De Walle H, da Graça Dutra M, Hirahara F, Martínez-Frías ML, Merlob P, Mutchinick O, Ritvanen A, Robert-Gnansia E, Scarano G, Siffel C, Stoll C, Mastroiacovo P.  Preferential associations between oral clefts and other major congenital anomalies. Cleft Palate Craniofac J. 2008; 45:525-32.
    [lire l’article ou l’extrait]
  89. Chevrier C, Bahuau M, Perret C, Iovannisci DM, Nelva A, Herman C, Vazquez MP, Francannet C, Robert-Gnansia E, Lammer EJ, Cordier S. Genetic susceptibilities in the association between maternal exposure to tobacco smoke and the risk of nonsyndromic oral cleft. Am J Med Genet A. 2008; 146A:2396-406.
    [lire l’article ou l’extrait]
  90. Leoncini E, Baranello G, Orioli IM, Annerén G, Bakker M, Bianchi F, Bower C, Canfield MA, Castilla EE, Cocchi G, Correa A, De Vigan C, Doray B, Feldkamp ML, Gatt M, Irgens LM, Lowry RB, Maraschini A, Mc Donnell R, Morgan M, Mutchinick O, Poetzsch S, Riley M, Ritvanen A, Robert-Gnansia E, Scarano G, Sipek A, Tenconi R, Mastroiacovo P.  Frequency of holoprosencephaly in the International Clearinghouse Birth Defects Surveillance Systems: searching for population variations. Birth Defects Res A Clin Mol Teratol. 2008; 82:585-91.
    [lire l’article ou l’extrait]
  91. Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol. 2008 Sep;26(1):24-30. Epub 2008 Jun 7.
    [lire l’article ou l’extrait]
  92. Lisi A, Botto LD, Robert-Gnansia E, Castilla EE, Bakker MK, Bianca S, Cocchi G, de Vigan C, Dutra Mda G, Horacek J, Merlob P, Pierini A, Scarano G, Sipek A, Yamanaka M, Mastroiacovo P. Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research. Reprod Toxicol. 2010 Jul;29(4):433-42. Epub 2010 Mar 27.
  93. Lisi A, Botto LD, Robert-Gnansia E, Castilla EE, Bakker MK, Bianca S, Cocchi G, de Vigan C, Dutra Mda G, Horacek J, Merlob P, Pierini A, Scarano G, Sipek A, Yamanaka M, Mastroiacovo P. Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research. Reprod Toxicol. 2010 Jul;29(4):433-42. Epub 2010 Mar 27.
    [lire l’article ou l’extrait]
IV. Letters to the Editor of international journals with editorial committee
  1. Robert E, Guibaud P. Maternal Valproic acid and congenital neural tube defects. Lancet, 1982, 2, 937.
  2. Bjerkedal T, Czeizel A, Goujard J, Källén B, Mastroiacovo P, Nevin N, Oakley G, Robert E. Valproic acid and spina bifida. Lancet, 1982, 2, 1096.
  3. Robert E, Rosa FW. Valproate and birth defects. Lancet, 1983, 2, 1142.
  4. Robert E, Löfkvist E, Mauguière F. Valproate and spina bifida. Lancet, 1984, 2, 1392.
  5. Robert E. Isotretinoin dose and teratogenicity. Lancet, 1988, 1, 236.
  6. Guibaud S, Robert E, Simplot A, Boisson C, Francannet C, Patouraux M-H. Prenatal diagnosis of spina bifida aperta after first trimester valproate exposure. Prenat Diagn, 1993, 13 : 772-3. [lire l’article ou l’extrait]
  7. Källén B, Pradat P, Robert E. Automobile accident during pregnancy. Reprod Toxicol, 1995, 9: 591.
  8. Mastroiacovo P, Robert E, Källén B. Is there an association of Down syndrome and omphalocele? Am J Med Genet, 1999, 82 : 443
  9. Källén B, Robert E. Response to “Case-control study using only malformed infants who were prenatally exposed to drugs. What do the results mean ? Teratology, 2000, 62 : 8-9.
  10. Mastroiacovo P, Robert-Gnansia E, Botto LD. Post-marketing surveillance and pregnancy: the MADRE project. BMJ, 10 March 2005, letter, Epub.
V. French journals with editorial committee
  1. Robert E, Robert JM. L’Acide Valproique est-il tératogène ? Rev Neurol, 1983, 139, 445-447.
  2. Robert E, Francannet C, Robert JM. Médicaments et Tératovigilance. Expérience en régions Rhône-Alpes Auvergne. Thérapie, 1985, 40, 293-96.
  3. Guibaud S, Robert E, Guibaud P, Robert JM. Traitement maternel par le valproate de sodium. Une indication d’amniocentèse. Presse Med 1985 ; 14 : 2299.
  4. Robert JM, Robert E, Francannet C. L’International Clearinghouse for Birth Defects Monitoring Systems. Un exemple de coopération internationale efficace. Arch Fr Pediatr 1986 ; 43 : 539-42.
  5. Danzon A, Robert E, Collet JP, Robert JM. Atrésies de l’oesophage. Etude d’un pic d’incidence observé en 1984 dans la région Rhône-Alpes. Arch Fr Pediatr, 1988, 45 : 231-235.
  6. Robert E, Francannet C, Robert JM. Le registre de malformations de la région Rhône-Alpes/Auvergne. J Gynecol Obstet Biol Reprod, 1988, 17, 601-607.
  7. Long S, Robert E, Laumon B, Pradat E, Robert JM. Epidémiologie des fentes labiales et palatines dans la région Rhône-Alpes, Auvergne, Jura. Pédiatrie, 1992, 47 : 133-140.
  8. Robert E, Pradat P, Laborier JC. Variations de prévalence de la trisomie 21 dans la région France/Centre-Est entre 1979 et 1993. BEH, 1997, 9:35-36.
  9. Goujard J, Aymé S, Robert E, Stoll C, de Vigan C, Dott B, Francannet C, Mendizabal H, Philip N, Vicard C, Vodovar V. Impact des actions de dépistage en France sur la prévalence des naissances malformées, période 1990-1994. BEH, 1997, 13 : 55-56.
  10. Bérard C, Pilliard D, Robert E et le groupe GERAM. La première consultation spécialisée d’un enfant présentant une agénésie unilatérale d’avant-bras. Arch Pédiatr, 1998, 5: 190-193.
  11. Bradaï R, Robert E. Diagnostic anténatal échographique chez la mère épileptique sous acide valproïque. Etude rétrospective de 161 cas du registre France/Centre-Est de malformations congénitales. J Gynecol Obstet Biol Reprod, 1998, 27 :413-419.
  12. Robert-Gnansia E. Méthodes d’évaluation des risques liés aux prises médicamenteuses pendant la grossesse. Avantages et limites de l’épidémiologie, interprétation des résultats. Thérapie, 2002 ; 57 : 175-180.
  13. Bonnot O, Vollset SE, Godet PF, d’Amato T, Dalery J, Robert E. Exposition in utero au lorazepam et atrésie anale : signal épidémiologique. L’Encéphale, 2003 ; XXIX : 553-9.
  14. Robert-Gnansia E, Francannet C. Un doublement de l’incidence des malformations congénitales en 20 ans ? Editorial ERS, 2004, 3 : 265-7.
  15. Gautheron S, Chevrier C, Laborier JC, Robert-Gnansia E. Prévalence des malformations congénitales autour des centrales nucléaires/Utilisation des données du registre France Centre-Est. ERS, 2004,4 :179-186.
  16. Gajdos V, Bahuau M, Robert-Gnansia E, Francannet C, Cordier S, Bonaïti-Pellié C. Genetics of nonsyndromic cleft lip with or without cleft palate: is there a Mendelian sub-entity?  Ann Genet. 2004 Jan-Mar;47(1):29-39.  [lire l’article ou l’extrait]
  17. Robert-Gnansia E, Amar E, Francannet C, Patouraux M-H, Bethenod I, Desvignes G, Pelamourgues D, Khoury J, Dumas I, Saez V, Laborier J-C, Cuoq C, Gaumet F. Le registre France Centre-Est* de malformations congénitales. Environnement, Risques et Santé. Vol. 4, n°6, nov-déc 2005. [lire l’article ou l’extrait]

Page modifiée le 17 juillet 2020.